---
title: "Beam Therapeutics Chief Legal Officer Christine Bellon Reports Disposal of Common Shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/273131199.md"
datetime: "2026-01-20T21:05:44.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/273131199.md)
  - [en](https://longbridge.com/en/news/273131199.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/273131199.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/273131199.md) | [繁體中文](https://longbridge.com/zh-HK/news/273131199.md)


# Beam Therapeutics Chief Legal Officer Christine Bellon Reports Disposal of Common Shares

Christine Bellon, Chief Legal Officer of Beam Therapeutics Inc., has reported a disposal of common shares of the company. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Beam Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-016552), on January 20, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [ProShares Ultra Nasdaq Biotechnology (BIB.US)](https://longbridge.com/en/quote/BIB.US.md)
- [VanEck Biotech ETF (BBH.US)](https://longbridge.com/en/quote/BBH.US.md)
- [First Trust NYSE Arca Biotech ETF (FBT.US)](https://longbridge.com/en/quote/FBT.US.md)
- [Direxion Daily S&P Biotech Bear 3X ETF (LABD.US)](https://longbridge.com/en/quote/LABD.US.md)
- [Beam Therapeutics Inc. (BEAM.US)](https://longbridge.com/en/quote/BEAM.US.md)
- [Invesco Nasdaq Biotechnology ETF (IBBQ.US)](https://longbridge.com/en/quote/IBBQ.US.md)
- [ALPS Medical Breakthroughs ETF (SBIO.US)](https://longbridge.com/en/quote/SBIO.US.md)
- [Invesco Biotechnology & Genome ETF (PBE.US)](https://longbridge.com/en/quote/PBE.US.md)
- [State Street® SPDR® S&P® Biotech ETF (XBI.US)](https://longbridge.com/en/quote/XBI.US.md)
- [iShares Biotechnology ETF (IBB.US)](https://longbridge.com/en/quote/IBB.US.md)

## Related News & Research

- [Beam Therapeutics Insider Sold Shares Worth $1,128,315, According to a Recent SEC Filing](https://longbridge.com/en/news/281490970.md)
- [Insider Confidence Surges as Tivic Health Systems Director Doubles Down](https://longbridge.com/en/news/281595239.md)
- [Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | XLO Stock News](https://longbridge.com/en/news/281660897.md)
- [Gaudium IVF Launches AI-Led Infertility Treatment in India First](https://longbridge.com/en/news/281416110.md)
- [09:00 ETDelonix Bioworks Announces Initiation of Phase 1 First-in-Human Clinical Trial of a Next-Generation MenB OMV Vaccine DX-104](https://longbridge.com/en/news/281025352.md)